Daiichi Sankyo Co. Ltd.

06/05/2023 | Press release | Distributed by Public on 06/05/2023 06:16

Datopotamab Deruxtecan Combinations Showed Encouraging Tumor Responses in Patients with Advanced Non-Small Cell Lung Cancer in TROPION-Lung02 Phase 1b trial (238.4KB